Skip to Main Content

Author Details

Yuzhuo Wang
University of British Columbia
2000
191
58
PMIDPaper TitleJournal TitlePublished Year
36351060Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer.Cancer Res2023
37490949PI3K/Akt signaling in urological cancers: Tumorigenesis function, therapeutic potential, and therapy response regulation.Eur J Pharmacol2023
37556934Establishment and validation of preclinical models of SMARCA4-inactivated and ARID1A/ARID1B co-inactivated dedifferentiated endometrial carcinoma.Gynecol Oncol2023
37605297Discovery of a First-in-Class Degrader for the Lipid Kinase PIKfyve.J Med Chem2023
37025467Genomic alterations in neuroendocrine prostate cancer: A systematic review and meta-analysis.BJUI Compass2023
37323470A personalized mRNA vaccine has exhibited potential in the treatment of pancreatic cancer.Holist Integr Oncol2023
37452083Influence of ADT on B7-H3 expression during CRPC progression from hormone-naïve prostate cancer.Cancer Gene Ther2023
37347559Chemokine receptor CXCR7 activates Aurora Kinase A and promotes neuroendocrine prostate cancer growth.J Clin Invest2023
37443749Dependency of Tamoxifen Sensitive and Resistant ER<sup>+</sup> Breast Cancer Cells on Semaphorin 3C (SEMA3C) for Growth.Cells2023
37342620Transcriptome analysis to identify candidate genes related to mammary gland development of Bactrian camel (<i>Camelus bactrianus</i>).Front Vet Sci2023
37075872Malignant function of nuclear factor-kappaB axis in prostate cancer: Molecular interactions and regulation by non-coding RNAs.Pharmacol Res2023
37035141Glucocorticoid mediated inhibition of LKB1 mutant non-small cell lung cancers.Front Oncol2023
36650259The future of patient-derived xenografts in prostate cancer research.Nat Rev Urol2023
36611121Chaperone-mediated autophagy promotes PCa survival during ARPI through selective proteome remodeling.Oncogene2023
36928314RB1-deficient prostate tumor growth and metastasis are vulnerable to ferroptosis induction via the E2F/ACSL4 axis.J Clin Invest2023
34767925Patient-derived xenograft models of neuroendocrine prostate cancer.Cancer Lett2022
35773731Molecular Landscape of LncRNAs in Prostate Cancer: A focus on pathways and therapeutic targets for intervention.J Exp Clin Cancer Res2022
35618012Pigment epithelium-derived factor maintains tight junction stability after myocardial infarction in rats through inhibition of the Wnt/β-catenin signaling pathway.Exp Cell Res2022
35661748Pigment epithelium-derived factor and its role in microvascular-related diseases.Biochimie2022
35563856Framework of Intrinsic Immune Landscape of Dormant Prostate Cancer.Cells2022
35524266Correction: The long and short non-coding RNAs modulating EZH2 signaling in cancer.J Hematol Oncol2022
35589014Long noncoding RNAs (lncRNAs) in pancreatic cancer progression.Drug Discov Today2022
36684065(Nano)platforms in bladder cancer therapy: Challenges and opportunities.Bioeng Transl Med2022
36109521Transcriptional profiling of matched patient biopsies clarifies molecular determinants of enzalutamide-induced lineage plasticity.Nat Commun2022
35963852Reformation of the chondroitin sulfate glycocalyx enables progression of AR-independent prostate cancer.Nat Commun2022
36358940Druggable Metabolic Vulnerabilities Are Exposed and Masked during Progression to Castration Resistant Prostate Cancer.Biomolecules2022
35317831Targeting autophagy in prostate cancer: preclinical and clinical evidence for therapeutic response.J Exp Clin Cancer Res2022
35152815Doxorubicin-loaded graphene oxide nanocomposites in cancer medicine: stimuli-responsive carriers, co-delivery and suppressing resistance.Expert Opin Drug Deliv2022
35064078Identification of alternative protein targets of glutamate-ureido-lysine associated with PSMA tracer uptake in prostate cancer cells.Proc Natl Acad Sci U S A2022
34937944Targeting SWI/SNF ATPases in enhancer-addicted prostate cancer.Nature2022
35236381The long and short non-coding RNAs modulating EZH2 signaling in cancer.J Hematol Oncol2022
35082166Modeling Androgen Deprivation Therapy-Induced Prostate Cancer Dormancy and Its Clinical Implications.Mol Cancer Res2022
33038264GRB10 sustains AR activity by interacting with PP2A in prostate cancer cells.Int J Cancer2021
33793068The evolutionarily conserved long non-coding RNA LINC00261 drives neuroendocrine prostate cancer proliferation and metastasis via distinct nuclear and cytoplasmic mechanisms.Mol Oncol2021
33766750Long non-coding RNAs in the doxorubicin resistance of cancer cells.Cancer Lett2021
33568749ZRSR2 overexpression is a frequent and early event in castration-resistant prostate cancer development.Prostate Cancer Prostatic Dis2021
33709547Androgen receptor (AR) antagonism triggers acute succinate-mediated adaptive responses to reactivate AR signaling.EMBO Mol Med2021
33639401The role of LR-TIMAP/PP1c complex in the occurrence and development of no-reflow.EBioMedicine2021
33750801A noncanonical AR addiction drives enzalutamide resistance in prostate cancer.Nat Commun2021
34934057The long noncoding RNA H19 regulates tumor plasticity in neuroendocrine prostate cancer.Nat Commun2021
34588438SPOP mutation induces DNA methylation via stabilizing GLP/G9a.Nat Commun2021
34599168SPOP mutation induces replication over-firing by impairing Geminin ubiquitination and triggers replication catastrophe upon ATR inhibition.Nat Commun2021
34676772<i>HAR1</i>: an insight into lncRNA genetic evolution.Epigenomics2021
33960594Establishment and characterization of a novel treatment-related neuroendocrine prostate cancer cell line KUCaP13.Cancer Sci2021
34290447Molecular events in neuroendocrine prostate cancer development.Nat Rev Urol2021
30927317ETS transcription factors as emerging drug targets in cancer.Med Res Rev2020
31964195The Open University's first one-day symposium on treatment-emergent neuroendocrine prostate cancer.Future Oncol2020
31806771Differential Expression of Glucose Transporters and Hexokinases in Prostate Cancer with a Neuroendocrine Gene Signature: A Mechanistic Perspective for <sup>18</sup>F-FDG Imaging of PSMA-Suppressed Tumors.J Nucl Med2020
33171818Lactic Acid and an Acidic Tumor Microenvironment suppress Anticancer Immunity.Int J Mol Sci2020
32938196EZH2 inhibition: a promising strategy to prevent cancer immune editing.Epigenomics2020
  • 1 - 50 of 191

Recommended Authors

Richard J Rebello
University of Melbourne
Career Start Year 2015
Number of shared co-authors 8
Wei Yuan
The Institute for Cancer Research
Career Start Year 2015
Number of shared co-authors 19
Natalie Kurganovs
Australian Prostate Cancer Research Centre Epworth
Career Start Year 2015
Number of shared co-authors 10
Yuliang Wang
The Chinese University of Hong Kong
Career Start Year 2014
Number of shared co-authors 8
Joshua Armenia
Oncology R&D
Career Start Year 2013
Number of shared co-authors 19
Brian W Simons
Center for Comparative Medicine, Baylor College of Medicine
Career Start Year 2008
Number of shared co-authors 18
Sungyong You
Cedars-Sinai Medical Center
Career Start Year 2008
Number of shared co-authors 22
Alok K Tewari
Dana-Farber Cancer Institute, Harvard Medical School
Career Start Year 2005
Number of shared co-authors 3
Scott A Tomlins
Rogel Cancer Center, University of Michigan Medical School ann arbor
Career Start Year 2003
Number of shared co-authors 76
Adam Sharp
The Institute for Cancer Research
Career Start Year 2003
Number of shared co-authors 25
Christopher E Barbieri
Weill Cornell Medical College
Career Start Year 2003
Number of shared co-authors 53
Tarek A Bismar
University of Calgary Cumming School of Medicine, Rockyview General Hospital
Career Start Year 2002
Number of shared co-authors 47
Luke A Selth
Adelaide Medical School, University of Adelaide
Career Start Year 2002
Number of shared co-authors 31
Michael Fraser
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2001
Number of shared co-authors 66
Sooryanarayana Varambally
University of Alabama at Birmingham, USA O'Neal Comprehensive Cancer Center
Career Start Year 2001
Number of shared co-authors 25
Nadia Boufaied
Research Institute of the McGill University Health Centre
Career Start Year 2000
Number of shared co-authors 19
Hayley C Whitaker
University College London
Career Start Year 1999
Number of shared co-authors 9
Srinivasan Yegnasubramanian
Johns Hopkins University School of Medicine
Career Start Year 1999
Number of shared co-authors 19
Phillip G Febbo
Illumina Inc.
Career Start Year 1997
Number of shared co-authors 37
Ian G Mills
Queen's University Belfast
Career Start Year 1997
Number of shared co-authors 21
Stanley K Liu
Odette Cancer Centre, University of Toronto
Career Start Year 1995
Number of shared co-authors 19
Ganesh V Raj
University of Texas Southwestern Medical Center at Dallas
Career Start Year 1994
Number of shared co-authors 29
Isla P Garraway
David Geffen School of Medicine University of California Los Angeles
Career Start Year 1993
Number of shared co-authors 28
Edwin M Posadas
Cedars-Sinai Medical Center
Career Start Year 1993
Number of shared co-authors 49
Rosina T Lis
National Cancer Institute
Career Start Year 1992
Number of shared co-authors 37
Bruce Montgomery
Fred Hutchinson Cancer Center, University of Washington
Career Start Year 1990
Number of shared co-authors 58
Guido Jenster
Erasmus University Medical Center
Career Start Year 1990
Number of shared co-authors 30
Christopher M Hovens
Royal Melbourne Hospital, The University of Melbourne
Career Start Year 1989
Number of shared co-authors 11
Tapio Visakorpi
Prostate Cancer Research Center, Tampere University and Tays Cancer Center
Career Start Year 1987
Number of shared co-authors 32
Beatrice S Knudsen
University of Utah
Career Start Year 1986
Number of shared co-authors 35

Collaborators

Colin C Collins
University of British Columbia
Co-authored papers 61
Dong Lin
Fujian Medical University Cancer Hospital and Fujian Cancer Hospital
Co-authored papers 58
Hui Xue
Agricultural Genomics Institute at Shenzhen, Chinese Academy of Agricultural Sciences
Co-authored papers 54
Martin E Gleave
University of British Columbia
Co-authored papers 51
Ladan Fazli
University of British Columbia
Co-authored papers 26
Anne Haegert
University of British Columbia
Co-authored papers 18
Fan Mo
Institute of Stem Cell and Regeneration, Chinese Academy of Sciences
Co-authored papers 15
Himisha Beltran
Dana-Farber Cancer Institute
Co-authored papers 15
Alexander W Wyatt
University of British Columbia
Co-authored papers 15
Xinpei Ci
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 13
Amina Zoubeidi
University of British Columbia
Co-authored papers 12
Stanislav V Volik
University of British Columbia
Co-authored papers 12
Mark A Rubin
University of Bern
Co-authored papers 11
Robert H Bell
University of British Columbia
Co-authored papers 11
Sonal Brahmbhatt
University of British Columbia
Co-authored papers 9
Akira Watahiki
Co-authored papers 8
Shawn Anderson
University of British Columbia
Co-authored papers 7
Wan L Lam
British Columbia Cancer Research Institute
Co-authored papers 7
Arul M Chinnaiyan
University of Michigan Medical School.
Co-authored papers 6
Poul H Sorensen
British Columbia Cancer Research Centre
Co-authored papers 6
Varune R Ramnarine
University of British Columbia
Co-authored papers 5
Felix Y Feng
UCSF Medical Center-Mount Zion
Co-authored papers 5
Elai Davicioni
Veracyte Inc.
Co-authored papers 5
Brian McConeghy
University of British Columbia
Co-authored papers 5
Suleyman Cenk Sahinalp
National Cancer Institute, National Institutes of Health
Co-authored papers 5
Marco A Marra
University of British Columbia
Co-authored papers 5
Antonio Hurtado-Coll
University of British Columbia
Co-authored papers 5
Kim N Chi
University of British Columbia
Co-authored papers 5
Robert Shukin
University of British Columbia
Co-authored papers 5
Anna Lapuk
Contextual Genomics Inc.
Co-authored papers 5
Release 1.2